New clinical data demonstrate the bioavailability of Lipomac, a clinically engineered liposomal vitamin C developed using Botanic Healthcare’s proprietary technology. The company says these findings prove that liposomal vitamin C is an effective strategy to overcome the “inherent absorption limitations” associated with traditional formulations.

The India-based supplier highlights that traditional vitamin C is easily broken down in the gastrointestinal tract, limiting the amount that reaches the circulation.

A clinical study in 12 healthy adults showed significantly increased systemic exposure following Lipomax supplementation, confirming enhanced absorption, improved gastrointestinal transit, and prolonged vitamin C circulation.

Dr HN Shivaprasad, Chief Scientific Officer, Botanic Healthcare said: “These findings validate the core science and engineering behind DFS technology and reinforce the measurable performance benefits of the liposomal format.”

liposome delivery

randomized open label, Crossover clinical research They compared the pharmacokinetics of Lipomac and conventional non-liposomal vitamin C in 12 adults divided into two treatment sequences.

The liposomal formulation achieved higher peak plasma concentrations than conventional vitamin C and approximately 2.36-fold higher relative bioavailability. The researchers note that this reflects improved absorption and systemic exposure.

“These results suggest that the liposome delivery system significantly increases the bioavailability of vitamin C and supports its use for more effective therapeutic delivery,” the study details.

Botanic Healthcare explains that the liposome delivery system uses biocompatible phospholipid vesicles to encapsulate the active ingredient. Therefore, they increase absorption in the intestine, protect against chemical and enzymatic degradation, and improve delivery to the body’s circulation.

“These results suggest that the liposomal delivery system significantly increases the bioavailability of vitamin C and supports its use for more effective therapeutic delivery,” the supplier states.

Madhu Krishnamani, Founder and Managing Director of Botanic Healthcare, added, “We are proud to drive health-focused solutions that are evidence-based and designed to deliver meaningful value to consumers around the world.”

Stabilization of vitamin C

The company developed Lipomac using its proprietary DFS technology. This patented platform is designed to stabilize sensitive active ingredients, enable targeted delivery, and maximize biological performance.

Gaurav Soni, one of the company’s founders and managing directors, said: “Lipomac demonstrates the company’s commitment to clinically-backed innovation and strengthens its position as the scientifically advanced partner of global nutraceutical brands.”

Lipomac is part of Botanic Healthcare’s Lipsobio portfolio of liposomal ingredients that include vitamins, minerals, nutraceuticals and botanical actives.

Each component in this range is authenticated through high-resolution imaging techniques, nanoscale structural mapping, stability and encapsulation profiling. in vitro Absorption experiments and clinical data.

last year, nutrition insights About how liposome technology became established in supplements in Southeast Asia. Wooree from Vitafoods Asia. The South Korean company has noticed that this delivery system, originally developed for drug delivery, is increasingly being used in nutritional supplements.

Meanwhile, we met with the authors of a recent study showing that: eat foods rich in vitamin C Increases vitamin C levels in the skin and supports collagen production more effectively than topical products.